Kai CUI,Julio Cesar CASTRO-PALOMINO LARIA,Weiyong KONG
申请号：
US16616844
公开号：
US20200163963A1
申请日:
2018.05.30
申请国别(地区):
US
年份:
2020
代理人:
摘要：
This application relates to various crystalline forms of 5-bromo-2,6-di(1H-pyrazol-1-yl)pyrimidin-4-amine and salt thereof, as well as compositions and methods of using the same. In some embodiments the crystalline forms also contain water (“hydrates”). These materials are useful in the treatment of various diseases, including carcinomas, specifically lung cancer and more specifically non-small cell lung cancer.
